应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02162 康诺亚-B
未开盘 11-01 16:08:36
43.650
+2.100
+5.05%
最高
43.900
最低
41.150
成交量
124.91万
今开
41.150
昨收
41.550
日振幅
6.62%
总市值
122.10亿
流通市值
122.10亿
总股本
2.80亿
成交额
5,382万
换手率
0.45%
流通股本
2.80亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 康诺亚-B(02162)午后涨超5% 司普奇拜单抗获批上市 商业化前景可期
智通财经 · 11-01 14:48
港股异动 | 康诺亚-B(02162)午后涨超5% 司普奇拜单抗获批上市 商业化前景可期
康诺亚-B(02162)上涨5.05%,报43.65元/股
金融界 · 11-01 13:48
康诺亚-B(02162)上涨5.05%,报43.65元/股
康诺亚-B盘中异动 大幅拉升5.05%
市场透视 · 11-01 13:48
康诺亚-B盘中异动 大幅拉升5.05%
康诺亚-B10月30日主力资金流入82万元 连续7日加仓
市场透视 · 10-30
康诺亚-B10月30日主力资金流入82万元 连续7日加仓
康诺亚-B盘中异动 急速下挫5.02%
市场透视 · 10-30
康诺亚-B盘中异动 急速下挫5.02%
康诺亚-B(02162)股价下跌5.018%,现价港币$40.7
阿斯达克财经 · 10-30
康诺亚-B(02162)股价下跌5.018%,现价港币$40.7
康诺亚-B(2162.HK)公告点评:司普奇拜单抗获批上市 商业化前景可期
光大证券 · 10-29
康诺亚-B(2162.HK)公告点评:司普奇拜单抗获批上市 商业化前景可期
康诺亚-B10月28日主力资金流入138万元 连续5日加仓
市场透视 · 10-28
康诺亚-B10月28日主力资金流入138万元 连续5日加仓
康诺亚-B(02162)下跌5.35%,报42.5元/股
金融界 · 10-28
康诺亚-B(02162)下跌5.35%,报42.5元/股
康诺亚-B盘中异动 股价大跌5.35%
市场透视 · 10-28
康诺亚-B盘中异动 股价大跌5.35%
康诺亚-B10月25日获主力加仓716万元 环比增加1093.33%
市场透视 · 10-25
康诺亚-B10月25日获主力加仓716万元 环比增加1093.33%
康诺亚-B10月24日主力资金流入60万元 连续3日加仓
市场透视 · 10-24
康诺亚-B10月24日主力资金流入60万元 连续3日加仓
康诺亚-B(02162)上涨5.36%,报45.25元/股
金融界 · 10-22
康诺亚-B(02162)上涨5.36%,报45.25元/股
康诺亚-B盘中异动 早盘快速上涨5.01%
市场透视 · 10-22
康诺亚-B盘中异动 早盘快速上涨5.01%
康诺亚-B10月18日获主力加仓331万元 环比增加6520.00%
市场透视 · 10-18
康诺亚-B10月18日获主力加仓331万元 环比增加6520.00%
康诺亚-B(02162)上涨5.11%,报43.2元/股
金融界 · 10-18
康诺亚-B(02162)上涨5.11%,报43.2元/股
康诺亚-B盘中异动 大幅拉升5.11%报43.200港元
市场透视 · 10-18
康诺亚-B盘中异动 大幅拉升5.11%报43.200港元
交银国际:予内地医药行业“领先”评级 关注创新和消费属性标的
智通财经 · 10-17
交银国际:予内地医药行业“领先”评级 关注创新和消费属性标的
康诺亚-B盘中异动 早盘快速拉升5.18%报42.650港元
市场透视 · 10-17
康诺亚-B盘中异动 早盘快速拉升5.18%报42.650港元
康诺亚-B(02162)股价上升5.179%,现价港币$42.65
阿斯达克财经 · 10-17
康诺亚-B(02162)股价上升5.179%,现价港币$42.65
暂无数据
公司概况
公司名称:
康诺亚-B
所属市场:
SEHK
上市日期:
--
主营业务:
Keymed Biosciences Inc是一家中国生物科技公司。该公司专注于自主发现及开发创新生物疗法以满足自体免疫及肿瘤治疗领域中未获满足的医疗需求。该公司已掌握内部药物发现及开发技术,其中包括构成其创新抗体发现平台及自有新型T细胞重定向(nTCE)双特异性抗体平台的技术。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要产品包括CM310、CM326以及CMG901等。
发行价格:
--
{"stockData":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"康诺亚-B","latestPrice":43.65,"timestamp":1730448516029,"preClose":41.55,"halted":0,"volume":1249082,"delay":0,"floatShares":279735566,"shares":279735566,"eps":-1.503469,"marketStatus":"未开盘","marketStatusCode":0,"change":2.1,"latestTime":"11-01 16:08:36","open":41.15,"high":43.9,"low":41.15,"amount":53824073,"amplitude":0.066185,"askPrice":43.65,"askSize":1000,"bidPrice":43.5,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-3.113456212109429,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730683800000},"adr":0,"listingDate":1625673600000,"adjPreClose":41.55,"openAndCloseTimeList":[[1730424600000,1730433600000],[1730437200000,1730448000000]],"volumeRatio":1.1352102000334885,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02162/tweets","defaultTab":"tweets","newsList":[{"id":"2480021102","title":"港股异动 | 康诺亚-B(02162)午后涨超5% 司普奇拜单抗获批上市 商业化前景可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2480021102","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480021102?lang=zh_cn&edition=full","pubTime":"2024-11-01 14:48","pubTimestamp":1730443715,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康诺亚-B午后涨超5%,截至发稿,涨3.97%,报43.2港元,成交额4147.62万港元。消息面上,中国国家药品监督管理局已于近日批准司普奇拜单抗的新药上市申请,适应症为成人中重度特应性皮炎。光大证券指出,司普奇拜单抗长期治疗可获得持续性临床获益,且安全性良好;司普奇拜单抗是首个国产且获得NMPA批准上市的IL-4Rα抗体药物。公司核心产品司普奇拜单抗获批上市,鉴于特应性皮炎患者群体庞大,市场广阔,维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","BK1574","BK1587","02162"],"gpt_icon":0},{"id":"2480302347","title":"康诺亚-B(02162)上涨5.05%,报43.65元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2480302347","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480302347?lang=zh_cn&edition=full","pubTime":"2024-11-01 13:48","pubTimestamp":1730440109,"startTime":"0","endTime":"0","summary":"11月1日,康诺亚-B(02162)盘中上涨5.05%,截至13:48,报43.65元/股,成交2677.15万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法,主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项,其中9项已进入不同阶段临床研发,多项位于中国第一,世界前三,包含一项世界首创ADC新药,两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2024年中报,康诺亚-B营业总收入5468.2万元、净利润-3.37亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/01134844827533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1161","BK1587","BK1574","02162"],"gpt_icon":0},{"id":"2480502315","title":"康诺亚-B盘中异动 大幅拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480502315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480502315?lang=zh_cn&edition=full","pubTime":"2024-11-01 13:48","pubTimestamp":1730440107,"startTime":"0","endTime":"0","summary":"2024年11月01日下午盘13时48分,康诺亚-B股票出现异动,股价大幅上涨5.05%。截至发稿,该股报43.650港元/股,成交量62.6582万股,换手率0.22%,振幅6.02%。康诺亚-B股票所在的生物技术行业中,整体涨幅为0.69%。其相关个股中,荣昌生物、盛禾生物-B、华昊中天医药-B涨幅较大,振幅较大的相关个股有来凯医药-B、荣昌生物、华昊中天医药-B,振幅分别为17.51%、15.56%、14.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110113482798e3feb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110113482798e3feb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02162","BK1587","BK1161","BK1574"],"gpt_icon":1},{"id":"2479221606","title":"康诺亚-B10月30日主力资金流入82万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2479221606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479221606?lang=zh_cn&edition=full","pubTime":"2024-10-30 16:15","pubTimestamp":1730276133,"startTime":"0","endTime":"0","summary":"10月30日, 康诺亚-B股价跌4.08%,报收41.10元,成交金额5612万元,换手率0.49%,振幅9.22%,量比1.24。康诺亚-B今日主力资金净流入82万元,连续7日净流入,上一交易日主力净流入136万元,今日环比减少39.71%。该股近5个交易日下跌7.24%,主力资金累计净流入1134万元;近20日主力资金累计净流入4340万元,其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030161553ab827a11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030161553ab827a11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","BK1587","02162"],"gpt_icon":0},{"id":"2479219831","title":"康诺亚-B盘中异动 急速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479219831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479219831?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:15","pubTimestamp":1730258134,"startTime":"0","endTime":"0","summary":"2024年10月30日早盘11时15分,康诺亚-B股票出现异动,股价大幅跳水5.02%。截至发稿,该股报40.700港元/股,成交量32.25万股,换手率0.12%,振幅7.35%。康诺亚-B股票所在的生物技术行业中,整体跌幅为0.96%。其相关个股中,荣昌生物、科济药业-B、康希诺生物涨幅较大,振幅较大的相关个股有科济药业-B、宜明昂科-B、康希诺生物,振幅分别为18.08%、11.78%、11.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030111534971a31ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030111534971a31ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1583","BK1587","02162"],"gpt_icon":0},{"id":"2479219160","title":"康诺亚-B(02162)股价下跌5.018%,现价港币$40.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2479219160","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479219160?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:15","pubTimestamp":1730258100,"startTime":"0","endTime":"0","summary":"[下跌股]康诺亚-B(02162) 股价在上午11:15比前收市价下跌5.018%,现股价为港币$40.7。至目前为止,今日最高价为$43.85,而最低价为$40.7。总成交量为32.25万股,总成交金额为港币$1.347千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD241030943/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","BK1583","02162","BK1587"],"gpt_icon":0},{"id":"2479401567","title":"康诺亚-B(2162.HK)公告点评:司普奇拜单抗获批上市 商业化前景可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2479401567","media":"光大证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479401567?lang=zh_cn&edition=full","pubTime":"2024-10-29 00:00","pubTimestamp":1730131200,"startTime":"0","endTime":"0","summary":"司普奇拜单抗是首个国产且获得NMPA 批准上市的IL-4Rα 抗体药物。截至2024 年9 月12 日,司普奇拜单抗治疗季节性过敏性鼻炎及慢性鼻窦炎伴鼻息肉的新药上市申请已获NMPA 受理。公司核心产品司普奇拜单抗获批上市,鉴于特应性皮炎患者群体庞大,市场广阔,我们维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410292027039f58dbde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410292027039f58dbde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1583","BK1574","02162"],"gpt_icon":0},{"id":"2478733611","title":"康诺亚-B10月28日主力资金流入138万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2478733611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478733611?lang=zh_cn&edition=full","pubTime":"2024-10-28 16:17","pubTimestamp":1730103429,"startTime":"0","endTime":"0","summary":"10月28日, 康诺亚-B股价跌4.01%,报收43.10元,成交金额4351万元,换手率0.36%,振幅6.01%,量比0.67。康诺亚-B今日主力资金净流入138万元,连续5日净流入,上一交易日主力净流入716万元,今日环比减少80.73%。该股近5个交易日上涨1.16%,主力资金累计净流入1425万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入5928万元,其中净流入天数为16日。该股主力净额占比0.01%,港股市场排名241/2644。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028161757a1f147ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028161757a1f147ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1583","BK1161","02162","BK1574"],"gpt_icon":0},{"id":"2478112051","title":"康诺亚-B(02162)下跌5.35%,报42.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2478112051","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478112051?lang=zh_cn&edition=full","pubTime":"2024-10-28 09:51","pubTimestamp":1730080290,"startTime":"0","endTime":"0","summary":"10月28日,康诺亚-B(02162)盘中下跌5.35%,截至09:51,报42.5元/股,成交1060.45万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法,主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项,其中9项已进入不同阶段临床研发,多项位于中国第一,世界前三,包含一项世界首创ADC新药,两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2024年中报,康诺亚-B营业总收入5468.2万元、净利润-3.37亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/28095144562017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1161","BK1574","BK1587","02162"],"gpt_icon":0},{"id":"2478117671","title":"康诺亚-B盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478117671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478117671?lang=zh_cn&edition=full","pubTime":"2024-10-28 09:51","pubTimestamp":1730080288,"startTime":"0","endTime":"0","summary":"2024年10月28日早盘09时51分,康诺亚-B股票出现异动,股价快速下跌5.35%。截至发稿,该股报42.500港元/股,成交量24.25万股,换手率0.09%,振幅5.57%。资金方面,该股资金流入221.33万港元,流出747.385万港元。康诺亚-B股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,华康生物医学、瑞科生物-B、贝康医疗-B涨幅较大,振幅较大的相关个股有云顶新耀-B、宜明昂科-B、晶泰科技,振幅分别为9.36%、8.38%、6.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102809512898e3eaa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102809512898e3eaa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1587","BK1161","02162","BK1574"],"gpt_icon":0},{"id":"2478677358","title":"康诺亚-B10月25日获主力加仓716万元 环比增加1093.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478677358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478677358?lang=zh_cn&edition=full","pubTime":"2024-10-25 16:16","pubTimestamp":1729844169,"startTime":"0","endTime":"0","summary":"10月25日, 康诺亚-B股价涨2.28%,报收44.90元,成交金额5995万元,换手率0.48%,振幅3.64%,量比0.93。康诺亚-B今日主力资金净流入716万元,连续4日净流入,上一交易日主力净流入60万元,今日环比增加1093.33%。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为66.67%,平均涨幅为3.15%。该股近5个交易日上涨1.35%,主力资金累计净流入1079万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入5894万元,其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025161633ab72eabc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025161633ab72eabc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","02162","BK1574","BK1583"],"gpt_icon":0},{"id":"2477508817","title":"康诺亚-B10月24日主力资金流入60万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2477508817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477508817?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:17","pubTimestamp":1729757829,"startTime":"0","endTime":"0","summary":"10月24日, 康诺亚-B股价跌0.68%,报收43.90元,成交金额3392万元,换手率0.28%,振幅4.41%,量比0.54。康诺亚-B今日主力资金净流入60万元,连续3日净流入,上一交易日主力净流入42万元,今日环比增加42.86%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为55.56%,平均涨幅为3.70%。该股近5个交易日上涨6.81%,主力资金累计净流入693万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入4995万元,其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024161749a1e649f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024161749a1e649f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1574","BK1587","BK1161","BK1583"],"gpt_icon":0},{"id":"2477219178","title":"康诺亚-B(02162)上涨5.36%,报45.25元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477219178","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477219178?lang=zh_cn&edition=full","pubTime":"2024-10-22 10:31","pubTimestamp":1729564287,"startTime":"0","endTime":"0","summary":"10月22日,康诺亚-B(02162)盘中上涨5.36%,截至10:31,报45.25元/股,成交1691.98万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法,主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项,其中9项已进入不同阶段临床研发,多项位于中国第一,世界前三,包含一项世界首创ADC新药,两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2024年中报,康诺亚-B营业总收入5468.2万元、净利润-3.37亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/22103144272819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02162","BK1583","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"2477821009","title":"康诺亚-B盘中异动 早盘快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477821009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477821009?lang=zh_cn&edition=full","pubTime":"2024-10-22 10:31","pubTimestamp":1729564284,"startTime":"0","endTime":"0","summary":"2024年10月22日早盘10时31分,康诺亚-B股票出现异动,股价快速上涨5.01%。截至发稿,该股报45.100港元/股,成交量37.9万股,换手率0.14%,振幅4.19%。机构评级方面,在所有8家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。康诺亚-B股票所在的生物技术行业中,整体涨幅为0.06%。康诺亚-B公司简介:康诺亚生物医药科技有限公司是一家生物科技公司,专注于自主发现及开发自体免疫及肿瘤治疗领域的创新生物疗法的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022103124971a182a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022103124971a182a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1583","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"2476472358","title":"康诺亚-B10月18日获主力加仓331万元 环比增加6520.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476472358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476472358?lang=zh_cn&edition=full","pubTime":"2024-10-18 16:16","pubTimestamp":1729239403,"startTime":"0","endTime":"0","summary":"10月18日, 康诺亚-B股价涨7.91%,报收44.35元,成交金额5038万元,换手率0.41%,振幅9.98%,量比1.03。康诺亚-B今日主力资金净流入331万元,连续3日净流入,上一交易日主力净流入5万元,今日环比增加6520.00%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为62.50%,平均涨幅为3.70%。该股近5个交易日上涨4.88%,主力资金累计净流入1461万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入5051万元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410181617129f4c9980&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410181617129f4c9980&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1574","BK1161","BK1583","BK1587"],"gpt_icon":0},{"id":"2476415678","title":"康诺亚-B(02162)上涨5.11%,报43.2元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2476415678","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476415678?lang=zh_cn&edition=full","pubTime":"2024-10-18 10:26","pubTimestamp":1729218392,"startTime":"0","endTime":"0","summary":"10月18日,康诺亚-B(02162)盘中上涨5.11%,截至10:26,报43.2元/股,成交924.02万元。康诺亚生物医药科技有限公司专注于研发高质量、可负担的创新疗法,主要业务包括分子发现、工艺开发、转化医学、临床开发到商业化生产药品开发全周期。公司自主研发的一类创新药逾30项,其中9项已进入不同阶段临床研发,多项位于中国第一,世界前三,包含一项世界首创ADC新药,两项获得国家“十三五”“重大新药创制”科技重大专项支持。截至2024年中报,康诺亚-B营业总收入5468.2万元、净利润-3.37亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/18102644143721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02162","BK1574","BK1161","BK1583","BK1587"],"gpt_icon":0},{"id":"2476168274","title":"康诺亚-B盘中异动 大幅拉升5.11%报43.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476168274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476168274?lang=zh_cn&edition=full","pubTime":"2024-10-18 10:26","pubTimestamp":1729218391,"startTime":"0","endTime":"0","summary":"2024年10月18日早盘10时26分,康诺亚-B股票出现波动,股价急速上涨5.11%。截至发稿,该股报43.200港元/股,成交量21.65万股,换手率0.08%,振幅4.74%。资金方面,该股资金流入551.378万港元,流出261.9万港元。康诺亚-B股票所在的生物技术行业中,整体跌幅为0.58%。其相关个股中,来凯医药-B、再鼎医药、三叶草生物-B涨幅较大,振幅较大的相关个股有再鼎医药、来凯医药-B、和誉-B,振幅分别为11.22%、10.04%、9.60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018102631971a0f5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018102631971a0f5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","BK1583","BK1161","02162"],"gpt_icon":1},{"id":"2476339061","title":"交银国际:予内地医药行业“领先”评级 关注创新和消费属性标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2476339061","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476339061?lang=zh_cn&edition=full","pubTime":"2024-10-17 09:53","pubTimestamp":1729129985,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,交银国际发表报告称,予内地医药行业“领先”评级。该行表示,第十批药品国采报量文件显示,此轮国采入围门槛历史最高、注射剂占历史最高,预计竞争将异常激烈,但对大多数处方药企来说,涉及大品种较少,影响或许有限。该行建议以最终品种名单为准。近期医药板块在市场投资情绪波动下大幅震荡,但考虑到先前板块估值已处于历史底部,该行认为仍有进一步修复空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195156.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","09926","00013","02162","01952"],"gpt_icon":0},{"id":"2476513860","title":"康诺亚-B盘中异动 早盘快速拉升5.18%报42.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476513860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476513860?lang=zh_cn&edition=full","pubTime":"2024-10-17 09:50","pubTimestamp":1729129855,"startTime":"0","endTime":"0","summary":"2024年10月17日早盘09时50分,康诺亚-B股票出现异动,股价快速拉升5.18%。截至发稿,该股报42.650港元/股,成交量6.35万股,换手率0.02%,振幅5.18%。资金方面,该股资金流入132.52万港元,流出95.585万港元。康诺亚-B股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,宜明昂科-B、康方生物、药明巨诺-B涨幅较大,振幅较大的相关个股有宜明昂科-B、荣昌生物、科笛-B,振幅分别为10.06%、7.73%、6.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017095055a1e14047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017095055a1e14047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02162","BK1161","BK1583","BK1587","BK1574"],"gpt_icon":0},{"id":"2476133254","title":"康诺亚-B(02162)股价上升5.179%,现价港币$42.65","url":"https://stock-news.laohu8.com/highlight/detail?id=2476133254","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476133254?lang=zh_cn&edition=full","pubTime":"2024-10-17 09:50","pubTimestamp":1729129800,"startTime":"0","endTime":"0","summary":"[上升股]康诺亚-B(02162) 股价在上午09:50比前收市价上升5.179%,现股价为港币$42.65。至目前为止,今日最高价为$42.65,而最低价为$40.55。总成交量为6.35万股,总成交金额为港币$265.482万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2410171494/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1574","BK1583","BK1587","02162"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0278},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.3514},{"period":"6month","weight":0.2261},{"period":"1year","weight":-0.224},{"period":"ytd","weight":-0.111}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.0863},{"period":"3month","weight":0.2101},{"period":"6month","weight":0.1099},{"period":"1year","weight":0.1901},{"period":"ytd","weight":0.2029}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Keymed Biosciences Inc是一家中国生物科技公司。该公司专注于自主发现及开发创新生物疗法以满足自体免疫及肿瘤治疗领域中未获满足的医疗需求。该公司已掌握内部药物发现及开发技术,其中包括构成其创新抗体发现平台及自有新型T细胞重定向(nTCE)双特异性抗体平台的技术。该公司还建立了涵盖生物药开发的关键功能的全面一体化平台。该公司主要产品包括CM310、CM326以及CMG901等。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.102216},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052845},{"month":3,"riseRate":0,"avgChangeRate":-0.111304},{"month":4,"riseRate":1,"avgChangeRate":0.048679},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.125967},{"month":6,"riseRate":1,"avgChangeRate":0.150041},{"month":7,"riseRate":0.333333,"avgChangeRate":0.066538},{"month":8,"riseRate":0.5,"avgChangeRate":0.01599},{"month":9,"riseRate":0.75,"avgChangeRate":0.035232},{"month":10,"riseRate":0.5,"avgChangeRate":0.051059},{"month":11,"riseRate":0.75,"avgChangeRate":0.080288},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.129089}],"exchange":"SEHK","name":"康诺亚-B","nameEN":"KEYMED BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康诺亚-B,02162,康诺亚-B股票,康诺亚-B股票老虎,康诺亚-B股票老虎国际,康诺亚-B行情,康诺亚-B股票行情,康诺亚-B股价,康诺亚-B股市,康诺亚-B股票价格,康诺亚-B股票交易,康诺亚-B股票购买,康诺亚-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康诺亚-B(02162)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康诺亚-B(02162)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}